| | |
| Clinical data | |
|---|---|
| Other names | 4-OH-MBT; 4-Hydroxy-N-methyl-N-butyltryptamine |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C15H22N2O |
| Molar mass | 246.354 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-HO-MBT, also known as 4-hydroxy-N-methyl-N-butyltryptamine, is a chemical compound of the tryptamine and 4-hydroxytryptamine families related to the psychedelic drug psilocin (4-HO-DMT). [1] [2] It was briefly described by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved), but was not tested by him and its properties and effects are unknown. [1] 4-HO-MBT was first described in the scientific literature by David Repke and colleagues in 1981. [2]
There are four possible isomers of 4-HO-MBT, with the others including 4-HO-MiBT, 4-HO-MsBT, and 4-HO-MtBT. [1] Of these, only 4-HO-MtBT has been tested as a possible psychedelic drug. [1] According to Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved), a dose of 15 mg 4-HO-MtBT orally produced virtually no effects. [1] Higher doses were not explored. [1]
Analogues of 4-HO-MBT include methylbutyltryptamine (MBT), 4-HO-MET (metocin), 4-HO-MPT (meprocin), psilocin (4-HO-DMT), and 4-HO-DBT, among others. [1]